Aurisco Pharmaceutical Hits Day Low at CNY 19.38 Amid Price Pressure

Aurisco Pharmaceutical Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, experienced a significant decline today, with its stock price dropping by 8.31% to reach an intraday low of CNY 19.38. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.05% during the same period. Over the past week, Aurisco's stock has decreased by 3.86%, while its monthly performance shows a slight increase of 0.1%. However, the annual performance reflects a more challenging landscape, with a decline of 12.83% compared to the Shanghai Composite's gain of 7.03%. Year-to-date, Aurisco has seen a notable drop of 22.44%. Financial metrics indicate that the company has a return on equity of 14.31% and a price-to-earnings ratio of 20.00. Despite a high dividend yield of 1.49%, the company faces challenges with its inventory turnover ratio at 1.1 times and a debtors turnover ratio of 4.24 times, both of which are at their lowest levels. These factors contribute to a complex financial picture for Aurisco Pharmaceutical Co. as it navigates current market conditions.